October 2018 | In The Back

@RetinaToday

Your Destination for the Latest Developments in #Retina in Print and Online

Share:

View PDF

TWEETS OF NOTE

Trending on RetinaToday.com

NEW DIRECTIONS ON THE DRUG DEVELOPMENT PATHWAY
By Thomas Ciulla, MD, MBA

Click the cover to read now!

October 2018

More from this issue

Recent Supplements

October 2026 Insert cover

Supporting Patients Throughout Their GA Journey

Editorially Independent Content, Supported With Advertising From Asetllas

View Insert

September 2026 Supplement cover

3 Years After Pegcetacoplan Approval: Addressing Post-Injection Complications and Understanding EZ:RPE Loss as a Potential Measure of Clinical Response

Content Sponsored by Apellis, A subsidiary of Biogen

View Supplement

September 2026 Supplement cover

Business Matters: Leveraging Data in the Retina Practice

Editorially independent content supported with advertising by Eyepoint

View Supplement

September 2026 Insert cover

One to Watch: Alexis Warren, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

September 2026 cover

Defining Early Geographic Atrophy Requires More Than Lesion Size

Editorially Independent Content, Supported With Advertising From Astellas

View Insert

September 2026 Insert cover

Rising Stars: Jonathan Lin, MD, PhD

Editorially independent supported by Abbvie and Regenxbio

View Insert

View More

Eyetube Retina Series

View More

EYETUBE RETINA MEETING COVERAGE

View More